Phase II trial of Combination Immunotherapy with nelipepimut-S + GM-CSF (NeuVax) and Trastuzumab in high risk HER2+ Breast Cancer patients.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/14 → 1/1/21

Funding

  • Galena Biopharma